These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3890277)

  • 1. Positron emission tomography and its application to the study of cerebrovascular disease in man.
    Powers WJ; Raichle ME
    Stroke; 1985; 16(3):361-76. PubMed ID: 3890277
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography in cerebrovascular disease.
    Powers WJ; Raichle ME
    Clin Neurosurg; 1983; 31():107-16. PubMed ID: 6333951
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron tomography in ischemic cerebrovascular disease.
    Frackowiak RS; Wise RJ
    Neurol Clin; 1983 Feb; 1(1):183-200. PubMed ID: 6334225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and metabolic studies in stroke.
    Hakin AM
    Semin Neurol; 1989 Dec; 9(4):286-92. PubMed ID: 2518338
    [No Abstract]   [Full Text] [Related]  

  • 5. [123I-IMP SPECT in ischemic cerebrovascular disorders--evaluation of delayed image].
    Murata J; Kaneko S; Imai T
    Kaku Igaku; 1988 Feb; 25(2):117-24. PubMed ID: 3260301
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a positron emission tomography study in two affected family members.
    Chabriat H; Bousser MG; Pappata S
    Stroke; 1995 Sep; 26(9):1729-30. PubMed ID: 7660422
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the 11CO2 positron emission tomographic method for measuring brain pH. II. Quantitative pH mapping in patients with ischemic cerebrovascular diseases.
    Senda M; Alpert NM; Mackay BC; Buxton RB; Correia JA; Weise SB; Ackerman RH; Dorer D; Buonanno FS
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):859-73. PubMed ID: 2511212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical neuroimaging approaches to cerebrovascular diseases.
    Davis KR; Kistler JP; Buonanno FS
    Neurol Clin; 1984 Nov; 2(4):655-65. PubMed ID: 6521713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood flow tomography by single photon emission computerized tomography using 133Xe in cerebrovascular disease.
    Lassen NA; Rommer P
    Monogr Atheroscler; 1986; 14():71-82. PubMed ID: 3090430
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebrovascular disease: use of fluorodeoxyglucose.
    Herholz K; Heiss WD
    Semin Neurol; 1989 Dec; 9(4):293-300. PubMed ID: 2701775
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of regional cerebral blood flow and redistribution phenomenon on 123I-IMP SPECT: its clinical significance in occlusive cerebral vascular disorders].
    Odano I; Tsuchiya T; Sakai K; Ito J
    Kaku Igaku; 1988 Aug; 25(8):789-99. PubMed ID: 3264033
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cerebral blood flow and oxygen metabolism: estimation by PET; with special respect to ischemic cerebrovascular disorders (series 4)].
    Ooboshi H; Fujishima M
    No Shinkei Geka; 1993 Apr; 21(4):290-7. PubMed ID: 8474582
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of positron emission tomography scanning in cerebral ischemia.
    Thomas DG; Gibbs JM; Wise RJ
    Clin Neurosurg; 1985; 32():51-69. PubMed ID: 3905150
    [No Abstract]   [Full Text] [Related]  

  • 14. Value of acute-stage positron emission tomography in predicting neurological outcome after ischemic stroke: further assessment.
    Marchal G; Rioux P; Serrati C; Furlan M; Derlon JM; Viader F; Baron JC
    Stroke; 1995 Mar; 26(3):524-5. PubMed ID: 7886737
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron CT imaging using a high resolution PCT device (Positologica-I), 11CO, 13NH3, and 18FDG in clinical evaluation of cerebrovascular diseases.
    Shishido F; Tateno Y; Takashima T; Tamachi S; Yamaura A; Yamasaki T
    Eur J Nucl Med; 1984; 9(6):265-71. PubMed ID: 6611260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is visible infarction on computed tomography associated with an adverse prognosis in acute ischemic stroke?
    Lenzi GL
    Stroke; 1998 Dec; 29(12):2665. PubMed ID: 9836783
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography study of regional glucose metabolism in cerebral ischemia--topographic and kinetic aspects.
    Pawlik G; Wienhard K; Herholz K; Wagner R; Heiss WD
    Prog Brain Res; 1984; 62():253-62. PubMed ID: 6335919
    [No Abstract]   [Full Text] [Related]  

  • 18. Positron emission tomography to assess cerebral perfusion.
    Powers WJ; Raichle ME; Grubb RL
    Lancet; 1985 Jan; 1(8420):102-3. PubMed ID: 2856999
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of positron emission tomography in cerebrovascular diseases.
    Baron JC
    Neurosurg Clin N Am; 1996 Oct; 7(4):653-64. PubMed ID: 8905777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3.
    Kuhl DE; Phelps ME; Kowell AP; Metter EJ; Selin C; Winter J
    Ann Neurol; 1980 Jul; 8(1):47-60. PubMed ID: 6967712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.